Asthma News – May 23-27, 2020
Current asthma research, announcements and opportunities, collected and distributed by Michigan Department of Health & Human Services Asthma Program Staff.
Sign up to receive weekly-ish news emails.
If you are English-speaking and 18 years of age or older, AAN invites you to participate in a survey on cannabis use and its impact on people with asthma, exercise-induced bronchospasm, allergic rhinitis, eczema and/or urticaria. The survey is confidential and anonymous, and it does not matter if you have never used cannabis, used cannabis in the past, or currently use cannabis.
The Asthma and Allergy Foundation of America and University of Michigan is asking physicians who take care of asthma patients to fill out a survey to determine how COVID-19 is changing asthma management for patients and providers.
The prevalence of adult asthma in the United States increased between 2009 and 2014 before levelling out between 2015 and 2018, according to a recent study.
Continued mepolizumab (NUCALA) was associated with decreased blood eosinophil count and exacerbations, as well as a longer time to exacerbations, compared to patients with asthma who discontinued therapy, according to new study findings.
A new study found that reducing the exposure to fine particles in living spaces using an air filtration device may improve airway mechanics, airflow limitation, and inflammation in children with asthma.
140 pulmonologists and allergists/immunologists from across the US completed a severe asthma survey, and analysis revealed that key challenges to providing care for patients with severe asthma included insurance company requirements and identification of the pathophysiology of an individual patient’s severe asthma.